Luke Evnin's Net Worth

$1.71 Million

Who is Luke Evnin?

Luke Evnin has an estimated net worth of $1.71 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., ARYx Therapeutics, Inc., PEPLIN INC, CRYOCOR INC, HEMOSENSE INC, COTHERIX INC, TERCICA INC, BARRIER THERAPEUTICS INC, TriVascular Technologies, Inc., RIGEL PHARMACEUTICALS INC, Entrada Therapeutics, Inc., Dyne Therapeutics, Inc., HEALTHCARE ACQUISITION CORP, AVEO PHARMACEUTICALS INC, XCYTE THERAPIES INC, NEORX CORP, ACORDA THERAPEUTICS INC, ARATANA THERAPEUTICS, INC., KALOBIOS PHARMACEUTICALS INC, Conatus Pharmaceuticals Inc, Epizyme, Inc., Cerecor Inc., CRITICAL THERAPEUTICS INC, Pharmasset Inc, Zalicus Inc., AFFYMAX INC, Somaxon Pharmaceuticals, Inc., HELICOS BIOSCIENCES CORP, SENORX INC, GENOME THERAPEUTICS CORP, Alsius Corp, Omrix Biopharmaceuticals, Inc., MEMORY PHARMACEUTICALS CORP, Harpoon Therapeutics, Inc., VIACELL INC, METROPCS COMMUNICATIONS INC, EnteroMedics Inc, iTeos Therapeutics, Inc., Restore Medical, Inc., Radius Health, Inc., Repare Therapeutics Inc., Verastem, Inc., Syndax Pharmaceuticals Inc, Pacira Pharmaceuticals, Inc., TCR2 THERAPEUTICS INC., TURMERIC ACQUISITION CORP., Werewolf Therapeutics, Inc., Oncorus, Inc., IPASS INC, CHIASMA, INC, IDENIX PHARMACEUTICALS INC, and METABASIS THERAPEUTICS INC.

SEC CIK

Luke Evnin's CIK is 0001134657

Past Insider Trading and Trends

2004 was Luke Evnin's most active year for acquiring shares with 7 total transactions. Luke Evnin's most active month to acquire stocks was the month of April. 2004 was Luke Evnin's most active year for disposing of shares, totalling 5 transactions. Luke Evnin's most active month to dispose stocks was the month of May. 2006 saw Luke Evnin paying a total of $200,000.00 for 157,525 shares, this is the most they've acquired in one year. In 2013 Luke Evnin cashed out on 22,746 shares for a total of $683,893.17, their largest year based on trade value.